Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis

Anne Skøttrup Mørkholt; Kenneth Kastaniegaard; Michael Sloth Trabjerg; Gopana Gopalasingam; Wanda Niganze; Michal Krystian Oklinski; Agnete Larsen; Jette G. K. Nieland; Allan Stensballe; Søren Nielsen; John Dirk Nieland

doi:10.7224/1537-2073-19.s1.1

Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis

Anne Skøttrup Mørkholt, Kenneth Kastaniegaard, Michael Sloth Trabjerg, Gopana Gopalasingam, Wanda Niganze, Michal Krystian Oklinski, Agnete Larsen, Jette G. K. Nieland, Allan Stensballe, Søren Nielsen, John Dirk Nieland

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	(NP01)
Tidsskrift	International Journal of MS Care
Vol/bind	19
Udgave nummer	Suppl. 1
Sider (fra-til)	54
ISSN	1537-2073
DOI	https://doi.org/10.7224/1537-2073-19.s1.1
Status	Udgivet - 2017
Begivenhed	Annual Meeting of the Consortium of Multiple Sclerosis Centers, CMSC - New Orleans, LA, USA Varighed: 24 maj 2017 → 27 maj 2017

Konference

Konference	Annual Meeting of the Consortium of Multiple Sclerosis Centers, CMSC
Land/Område	USA
By	New Orleans, LA
Periode	24/05/2017 → 27/05/2017

Adgang til dokumentet

10.7224/1537-2073-19.s1.1

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

1 Ph.d.-afhandling

Carnitine Palmitoyl Transferase 1 – a Potential Target to Restore Dysregulated Metabolism in Neurodegenerative Diseases? based on in vivo models mimicking Amyotrophic Lateral Sclerosis, Parkinson's Disease and Mutiple Sclerosis
Bidragets oversatte titel: Carnitine Palmitoyl Transferase 1 – et potentielt target til at revertere dysreguleret metabolisme i neurodegenerative sygdomme?: baseret på in vivo modeller for Amyotrofisk Lateral Sclerose, Parkinson’s Sygdom og Multiple ScleroseTrabjerg, M., 2020, Aalborg Universitetsforlag. 113 s.
Publikation: Ph.d.-afhandling

Åben adgang
Fil

238 Downloads (Pure)

Citationsformater

Mørkholt, A. S., Kastaniegaard, K., Trabjerg, M. S., Gopalasingam, G., Niganze, W., Oklinski, M. K., Larsen, A., Nieland, J. G. K., Stensballe, A., Nielsen, S., & Nieland, J. D. (2017). Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis. International Journal of MS Care, 19(Suppl. 1), 54. Artikel (NP01). https://doi.org/10.7224/1537-2073-19.s1.1

@article{e654f5a6a6bb497f92c163b9d9fd4219,

title = "Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis",

author = "M{\o}rkholt, {Anne Sk{\o}ttrup} and Kenneth Kastaniegaard and Trabjerg, {Michael Sloth} and Gopana Gopalasingam and Wanda Niganze and Oklinski, {Michal Krystian} and Agnete Larsen and Nieland, {Jette G. K.} and Allan Stensballe and S{\o}ren Nielsen and Nieland, {John Dirk}",

year = "2017",

doi = "10.7224/1537-2073-19.s1.1",

language = "English",

volume = "19",

pages = "54",

journal = "International Journal of MS Care",

issn = "1537-2073",

publisher = "Delaware Media Group",

number = "Suppl. 1",

note = "Annual Meeting of the Consortium of Multiple Sclerosis Centers, CMSC ; Conference date: 24-05-2017 Through 27-05-2017",

}

Mørkholt, AS, Kastaniegaard, K, Trabjerg, MS, Gopalasingam, G, Niganze, W, Oklinski, MK, Larsen, A, Nieland, JGK, Stensballe, A, Nielsen, S & Nieland, JD 2017, 'Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis', International Journal of MS Care, bind 19, nr. Suppl. 1, (NP01), s. 54. https://doi.org/10.7224/1537-2073-19.s1.1

Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis. / Mørkholt, Anne Skøttrup; Kastaniegaard, Kenneth; Trabjerg, Michael Sloth et al.
I: International Journal of MS Care, Bind 19, Nr. Suppl. 1, (NP01), 2017, s. 54.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis

AU - Mørkholt, Anne Skøttrup

AU - Kastaniegaard, Kenneth

AU - Trabjerg, Michael Sloth

AU - Gopalasingam, Gopana

AU - Niganze, Wanda

AU - Oklinski, Michal Krystian

AU - Larsen, Agnete

AU - Nieland, Jette G. K.

AU - Stensballe, Allan

AU - Nielsen, Søren

AU - Nieland, John Dirk

PY - 2017

Y1 - 2017

U2 - 10.7224/1537-2073-19.s1.1

DO - 10.7224/1537-2073-19.s1.1

M3 - Conference abstract in journal

SN - 1537-2073

VL - 19

SP - 54

JO - International Journal of MS Care

JF - International Journal of MS Care

IS - Suppl. 1

M1 - (NP01)

T2 - Annual Meeting of the Consortium of Multiple Sclerosis Centers, CMSC

Y2 - 24 May 2017 through 27 May 2017

ER -

Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis

Konference

Adgang til dokumentet

AUB Link

Publikation

Carnitine Palmitoyl Transferase 1 – a Potential Target to Restore Dysregulated Metabolism in Neurodegenerative Diseases? based on in vivo models mimicking Amyotrophic Lateral Sclerosis, Parkinson's Disease and Mutiple Sclerosis

Citationsformater